Sygnature Discovery Appoints Amira Modi as New Chief Operating Officer and Board Member

World-leading contract research organization (CRO) Sygnature Discovery is delighted to announce the appointment of Amira Modi as its new Chief Operating ...

October 04, 2024 | Friday | News
Transforming Vision: Jacqueline Henderson on Johnson & Johnson's Groundbreaking IOL Innovations

As President of EMEA at Vision Johnson & Johnson, Jacqueline Henderson is at the forefront of innovation in ophthalmology, overseeing the development...

October 01, 2024 | Tuesday | Interview
Eli Lilly CEO David Ricks Announces Major Expansion of India Research Hub, Poised to Transform Global Drug Innovation

Eli Lilly and Company (NYSE: LLY), a global leader in biopharmaceuticals, has announced plans to expand its research and development (R&D) center in ...

September 24, 2024 | Tuesday | News
The Future of Synthetic Biology: Streamlining Innovation With New Technology

Clore and Ottensmann explain:   Synthetic biology is revolutionizing medical treatments for a wide range of diseases. It’s what made it possib...

September 18, 2024 | Wednesday | Expert Opinion
Enzene Biosciences Appoints Norm Stoffregen as SVP and Head of New $50 Million Biologics Manufacturing Facility in New Jersey

Enzene Biosciences, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced the appointment of Norm St...

September 04, 2024 | Wednesday | News
MasterControl Appoints Kelly Starman as Chief Marketing Officer to Drive Global Growth

MasterControl, a leading provider of quality management and manufacturing software solutions, today announced the appointment of Kelly Starman as Chief M...

August 15, 2024 | Thursday | News
Merck CEO Belén Garijo Drives Up 2024 Growth Forecast as Q2 Results Reflect Robust Performance in Healthcare and Electronics

Financial results of Q2 2024 Group net sales up organically by 1.7% to € 5.4 billion EBITDA pre down 0.8% organically to € 1...

August 12, 2024 | Monday | Company results
Twist Bioscience Surpasses Revenue Guidance with $81.5 Million, Says CEO Emily M. Leproust; Highlights Strength in NGS and SynBio Product Lines

– Record revenue of $81.5M in 3QFY24, an increase of 28% over $63.7M in 3QFY23 – – Gross margin improved to 43.3% in 3QFY24, incre...

August 05, 2024 | Monday | Company results
IDT Pioneers CRISPR Safety and Accuracy with Advanced Technologies

  In a recent Q&A session with BioPharma BoardRoom, Gavin Kurgan, Bioinformatics Applications Development Manager at Integrated DNA Technologies ...

July 29, 2024 | Monday | Interaction
Thermo Fisher Chairman Marc N. Casper Attributes Success to Proven Growth Strategy and Welcomes Olink Colleagues

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 29...

July 24, 2024 | Wednesday | Company results
IQVIA CEO Ari Bousbib Reports Strong Q2 Results, Exceeding Expectations and Driving Growth

Revenue of $3,814 million GAAP Net Income of $363 million, Adjusted EBITDA of $887 million GAAP Diluted Earnings per Share of $1.97, Adjusted D...

July 23, 2024 | Tuesday | Company results
Shanghai Junshi Biosciences' sNDA for Toripalimab and Bevacizumab Combo for Advanced Liver Cancer Accepted by NMPA

  Shanghai Junshi Biosciences Co., a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...

July 19, 2024 | Friday | News
Boehringer Ingelheim Chairman von Baumbach Highlights Strong H1 2024 Performance and Pipeline Milestones

Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncology Further data read-outs expected in 2024 in oncology, mental health, ...

July 18, 2024 | Thursday | News
Paul Limburg Highlights Commitment to Reducing Screening Disparities Through the FOCUS Program's Support of 28 Organizations Nationwide

  Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced  that it awarded a total of $1.5 million to 28 organiza...

July 18, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close